# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascula...
Avinger (NASDAQ:AVGR) reported quarterly losses of $(2.49) per share which missed the analyst consensus estimate of $(1.35) by ...
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-th...
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Avinger (NASDAQ:AVGR) with a Buy and maintains $5 price ta...